Valuation
Login to View
Max Portfolio %
Login to View
Last 7 days
-7.6%
Last 30 days
153.1%
Last 90 days
102.5%
Trailing 12 Months
99.2%
NAUT RSI Chart
Valuation
Login to View
Max Portfolio %
Login to View
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
How Nautilus Biotechnology, Inc. generates revenue and covers its expenses, based on the latest reported earnings.
| CEO | Mr. Sujal M. Patel |
|---|---|
| WEBSITE | nautilus.bio |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 153 |